The progression in the mouse skin carcinogenesis model correlates with ERK1/2 signaling

Molecular Medicine

Volumn 8, Issue 10, 2002, Pages 624-637

  Katsanakis, Kostas D ^a   Gorgoulis, Vassilis ^b   Papavassiliou, Athanasios G ^c   Zoumpourlis, Vassilis K ^a  

^a INSTITUTE OF BIOLOGY   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c UNIVERSITY OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CARCINOGEN; DIMETHYLBENZ[A]ANTHRACENE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; KERATINOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKIN CANCER; SKIN CARCINOGENESIS; SPINDLE CELL;

EID: 0036821563     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03402173     Document Type: Article

References (62)

1. Barbacid M. (1987) ras genes. Annu. Rev. Biochem. 56: 779-827.
2. Frame S, Crombie S, Liddell J, et al. (1998) Epithelial carcinogenesis in the mouse: correlating the genetics and the biology. Philos. Trans. R. Soc. Lond. B Biol. Sci. 353: 839-845.
3. Balmain A, Brown K. (1988) Oncogene activation in chemical carcinogenesis. Adv. Cancer Res. 5: 147-182.
4. Quintanilla M, Haddow S, Jonas D, Jaffe D, Bowden GT, Balmain A. (1991) Comparison of ras activation during epidermal carcinogenesis in vitro and in vivo. Carcinogenesis 12: 1875-1881.
5. Buchmann A, Ruggeri B, Klein-Szanto AJ, Balmain A. (1991) Progression of squamous carcinoma cells to spindle carcinomas of mouse skin is associated with an imbalance of H-ras alleles on chromosome 7. Cancer Res. 51: 4097-4101.
6. Troppmair J, Bruder JT, Munoz H, et al. (1994) Mitogen-activated protein kinase/extracellular signal-regulated protein kinase activation by oncogenes, serum, and 12-0-tetradecanoylphorbol-13-acetate requires Raf and is necessary for transformation. J. Biol. Chem. 269: 7030-7035.
7. Khosravi-Far R, Solski PA, Clark GJ, Kinc MS, Der CJ. (1995) Activation of Racl, RhoA, and mitogen-activated protein kinases is required for Ras transformation. Mol. Cell Biol. 15: 6443-6453.
8. Khosravi-Far R, White MA, Westwick JK, et al. (1996) Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation. Mol. Cell Biol. 16: 3923-3933.
9. Rodriguez-Viciana P, Warne PH, Dhand R, et al. (1994) Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 370: 527-532.
10. Diaz-Meco MT, Lozano J, Municio MM, et al. (1994) Evidence for the in vitro and in vivo interaction of Ras with protein kinase C zeta. J. Biol. Chem. 269: 31706-31710.
11. Russell M, Lange-Carter CA, Johnson GL. (1995) Direct interaction between Ras and the kinase domain of mitogen-activated protein kinase kinase kinase (MEKK1). J. Biol. Chem. 270: 11757-11760.
12. Boguski MS, McCormick F. (1993) Proteins regulating Ras and its relatives. Nature 366: 643-654.
13. White MA, Vale T, Camonis JH, Schaefer E, Wigler MH. (1996) A role for the Ral guanine nucleotide dissociation stimulator in mediating Ras-induced transformation. J. Biol. Chem. 271: 16439-16442.
14. Zoumpourlis V, Papassava P, Linardopoulos S, Gillespie D, Balmain A, Pintzas A. (2000) High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model. Oncogene 19: 4011-4021.
15. Fusenig NE, Drazlieva-Petrusevska RT, Breitkreutz D. (1985) Phenotypic and cytogenetic characteristics of different stages during spontaneous transformation of mouse keratinocytes in vitro. Carcinog. Compr. Surv. 9: 293-326.
16. Spandidos DA, Wilkie NM. (1984) Malignant transformation of early passage rodent cells by a single mutated human oncogene. Nature 310: 469-475.
17. Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR. (1995) A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. U.S.A. 92: 7686-7689.
18. Diaz-Guerra M, Haddow S, Baulur C, et al. (1992) Expression of simple epithelial keratins in mouse epidermal keratinocytes harbouring Harvey ras gene alterations. Cancer Res. 52: 680-687.
19. Burns PA, Kemp CJ, Gannon JV, Lane DP, Bremner R, Balmain A. (1991) Loss of heterozygosity and mutational alterations of the p53 gene in skin tumors of interspecific hybrid mice. Oncogene 6: 2363-2369.
20. Haddow S, Fowlis DJ, Parkinson K, Akhurst RJ, Balmain A. (1991) Loss of growth control by TGF-β occurs at a late stage of mouse skin carcinogenesis and is dependent of ras gene activation. Oncogene 6: 1465-1470.
21. Bremner R, Balmain A. (1990) Genetic changes in skin tumor progression: correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7. Cell 61: 407-417.
22. Quintanilla M, Brown K, Ramsden M, Balmain A. (1986) Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature 322: 78-80.
23. Papathoma A, Zoumpourlis V, Balmain A, Pintzas A. (2001) The role of matrix metalloproeinase-9 in progression of mouse skin carcinogenesis. Mol. Carcinog. 31: 74-82.
24. Stacey DW, Tsai MH, Yu CL, Smith JK. (1988) Critical role of cellular ras proteins in proliferative signal transduction. Cold Spring Harb. Symp. Quant. Biol. 53: 871-881.
25. Waters SB, Holt KH, Ross SE, et al. (1995) Desensitization of Ras activation by a feedback disassociation of the SOS-Grb2 complex. J. Biol. Chem. 270: 20883-20886.
26. Pang L, Sawada T, Decker SJ, Saltiel AR. (1995) Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J. Biol. Chem. 270: 13585-13588.
27. Shin SI, Freedman VH, Risser R, Pollack R. (1975) Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro. Proc. Natl. Acad. Sci. U.S.A. 72: 4435-4439.
28. Shirasawa S, Furuse M, Yokoyama N, Sasazuki T. (1993) Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science 260: 85-88.
29. Lallemand D, Spyrou G, Yaniv M, Pfarr CM. (1997) Variations in Jun and Fos protein expression and AP-1 activity in cycling, resting and stimulated fibroblasts. Oncogene 14: 819-830.
30. Gruda MC, Kovary K, Metz R, Bravo R. (1994) Regulation of Fra-1 and Fra-2 phosphorylation differs during the cell cycle of fibroblasts and phosphorylation in vitro by MAP kinase affects DNA binding activity. Oncogene 9: 2537-2547.
31. Treinies I, Paterson HF, Hooper S, wilson R, Marshall CJ.(1999) Activated MEK stimulates expression of AP-1 components independently of phosphatidylinositol 3-kinase (PI3-kinase) but requires a PI3-kinase signal to stimulate DNA synthesis. Mol. Cell Biol. 19: 321-329.
32. Sporn MB, Todaro GJ. (1980) Autocrine secretion and malignant transformation of cells. N. Engl. J. Med. 303: 878-880.
33. MacDougall JR, Matrisian LM. (1995) Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev. 14: 351-362.
34. Gum R, Wang H, Lengyel E, Juarez J, Boyd D. (1997) Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades. Oncogene 14: 1481-1493.
35. Brown K, Buchmann A, Balmain A. (1989) Carcinogen-induced mutations in the mouse c-Ha-ras gene provide evidence of multiple pathways for tumor progression. Proc. Natl. Acad. Sci. U.S.A. 87: 538-542.
36. Karin M. (1995) The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270: 16483-16486.
37. Sivaraman VS, Wang H, Nuovo GJ, Malbon CC. (1997) Hyperexpression of mitogen-activated protein kinase in human breast cancer. J. Clin. Invest. 99: 1478-1483.
38. Wood KW, Sarnecki C, Roberts TM, Blenis J. (1992) ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSK. Cell 68: 1041-1050.
39. Leevers SJ, Marshall CJ. (1992) Activation of extracellular signal-regulated kinase, ERK2, by p21ras oncoprotein. EMBO J. 11: 569-574.
40. Qui MS, Green SH. (1992) PC12 cell neuronal differentiation is associated with prolonged p21ras activity and consequent prolonged ERK activity. Neuron 9: 705-717.
41. Sebolt-Leopold JS, Dudley DT, Herrera R, et al. (1999) Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nat. Med. 5: 810-816.
42. Thiery JP, Chopin D. (1999) Epithelial cell plasticity in development and tumor progression. Cancer Metastasis Rev. 18: 31-42.
43. Oft M, Peli J, Rudaz C, Schwarz H, Beug H, Reichmann E. (1996) TGF-beta1 and Ha-ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev. 10: 2462-2477.
44. Oft M, Heider KH, Beug H. (1998) TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis. Curr. Biol. 19: 1243-1252.
45. Lehmann K, Janda E, Pierreux CE, et al. (2000) Raf induces TGFbeta production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells. Genes Dev. 14: 2610-2622.
46. Caulin C, Scholl FG, Frontelo P, Gamallo C, Quintanilla M. (1995) Chronic exposure of cultured transformed mouse epidermal cells to transforming growth factor-beta 1 induces an epithelial-mesenchymal transdifferentiation and a spindle tumoral phenotype. Cell Growth Differ. 6: 1027-1035.
47. Jouanneau J, Gavrilovic J, Caruelle D, et al. (1991) Secreted or nonsecreted forms of acidic fibroblast growth factor produced by transfected epithelial cells influence cell morphology, motility, and invasive potential. Proc. Natl. Acad Sci. U.S.A. 88: 2893-2897.
48. Redmond SM, Reichmann E, Muller RG, Friis RR, Groner B, Hynes NE. (1988) The transformation of primary and established mouse mammary epithelial cells by p21-ras is concentration dependent. Oncogene 2: 259-265.
49. Reichmann E, Schwarz H, Deiner EM, et al. (1992) Activation of an inducible c-FosER fusion protein causes loss of epithelial polarity and triggers epithelial-fibroblastoid cell conversion. Cell 7: 1103-1116.
50. Stoler AB, Stenback F, Balmain A. (1993) The conversion of mouse skin squamous cell carcinomas to spindle cell carcinomas is a recessive event. J. Cell Biol. 122: 1103-1117.
51. Zhong C, Kinch MS, Burridge K. (1997) Rho-stimulated contractility contributes to the fibroblastic phenotype of Rastransformed epithelial cells. Mol. Biol. Cell 8: 2329-2344.
52. Kinch MS, Clark GJ, Der CJ, Burridge K. (1995) Tyrosine phosphorylation regulates the adhesions of ras-transformed breast epithelia. J. Cell Biol. 130: 461-471.
53. Behrens J, Vakaet L, Friis R, et al. (1993) Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature-sensitive v-SRC gene. J. Cell Biol. 120: 757-766.
54. Zondag GC, Evers EE, ten Klooster JP, et al. (2000) Oncogenic Ras downregulates Rac activity, which leads to increased Rho activity and epithelial-mesenchymal transition. J. Cell Biol. 149: 775-782.
55. de Larco JE, Todaro GJ. (1978) Growth factors from murine sarcoma virus-transformed cells. Proc. Natl. Acad. Sci. U.S.A. 75: 4001-4005.
56. Scher CD, Pledger WJ, Martin P, Antoniades H, Stiles CD. (1978) Transforming viruses directly reduce the cellular growth requirement for a platelet derived growth factor. J. Cell Physiol. 97: 371-380.
57. Ozanne B, Fulton RJ, Kaplan PL. (1980) Kirsten murine sarcoma virus transformed cell lines and a spontaneously transformed rat cell-line produce transforming factors. J. Cell Physiol. 105: 163-180.
58. Gangarosa LM, Sizemore N, Graves-Deal R, Oldham SM, Der CJ, Coffey RJ. (1977) A raf-independent epidermal growth factor receptor autocrine loop is necessary for Ras transformation of rat intestinal epithelial cells. J. Biol. Chem. 272: 18926-18931.
59. Ozanne BW, McGarry L, Spence HJ, et al. (2000) Transcriptional regulation of cell invasion: AP-1 regulation of a multigenic invasion programme. Eur. J. Cancer 36: 1640-1648.
60. Cook SJ, McCormick F. (1996) Kinetic and biochemical correlation between sustained p44ERK1 (44 kDa extracellular signal-regulated kinase 1) activation and lysophosphatidic acid-stimulated DNA synthesis in Rat-1 cells. Biochem. J. 320: 237-245.
61. Traverse S, Seedorf K, Paterson H, Marshall CJ, Cohen P, Ullrich A. (1994) EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor. Curr. Biol. 4: 694-701.
62. Traverse S, Gomez N, Paterson H, Marshall C, Cohen P. (1992) Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. Biochem. J. 288: 351-355.